Ukraine Trade Data of Drug Imports Under HS Code 300490
Lookup Ukraine trade data of drug imports under HS code 300490. Check Ukraine import trading parters of drug
248 Shipments Records (Demo)
300490 
| Date | HS Code | Product Description | Origin Country | Quantity | Unit | Net Weight | Total Value [USD] | Importer Name | Click to view 16 more columns 16 More Columns Available |
|---|---|---|---|---|---|---|---|---|---|
| 28/Apr/2017 | 3004900000 | 1.likarskyy remedy: heparyzyn injection, in 20 ml vials, 10 vials labeled carton pack ukrainian-language 2010pachok.�route of administration: intravenous.�atc code: a05v a. indications: improving excited funktsiyipechinky chronic diseases nky furnace.�active substance: monoamoniyuhlitsyryn yzatu glycyrrhizin equivalent to 40 mg, 400 mg hli tin, l-tsysteyinuhidrohlorydu 20mg.�excipients: sodium sulfite bezvo dnyy, sodium chloride, water for injection, concentrated ammonia solution.�serial number: 09170307. datavyhotovlennya: 10.03.2017r.�shelf life: 09.03.2020r.�mistytozonoruynuyuchyh not matter, not the narcotic drugs, psychotropic noyurechovynoyu and prekursorom.vyrobnyk: beijing kawin technology share-holding co., ltd.krayina production: cn.torhivelna brand: heparyzyn.�. | CHINA | ****** | UA125100 | 783.90 | 21,896.14 | ***** | 16 More Columns Available along with Company Name and Other Details etc. |
| 28/Apr/2017 | 3004900000 | "1. drugs (medicines for humans), in packages for retail, not vaerozolniy box, free of drugs and precursors, chewable tablets konehradelyuks to 50 mg 1 tablet in blister, 1 blister vkartonniy box. active ingredients: 1 tablet contains sildenafil sildenafil 50 mg equivalent tsytratu70, 24mh. series: 170724-8952up. konehra delyukstabletky to 50 mg chewable tablets in 4 blister, 1 blister in kartonniykorobtsi. active substance: 1 tablet contains sildenafil citrate sildenafil 50 mg 70, 24mhekvivalentno. series 17�0729-11682up. konehra deluxe tabletkyzhuvalni to 100 mg 1 tablet in blister, 1 blister in carton korobtsi.diyuchi substances: 1 tablet contains sildenafil citrate 100mg 140, 48mh ekvivalentnosyldenafilu. series: 170732-8910up. konehra chewable tablets deluxe po100mh 4 tablets in a blister, 1 blister in a cardboard box. diyuchirechovyny: 1 tablet contains sildenafil citrate 100mg 140, 48mh ekvivalentnosyldenafilu. series: 1703 39-11585up.torhivelna mark - "" konehra deluxe "." producer - "" henefarm sa ", " greece .krayina production - gr (greece).�marking vstanovlenymzakonodavstvom available and meets the standards. " | GREECE | ****** | UA125110 | 499 | 51,162.43 | ***** | |
| 28/Apr/2017 | 3004900000 | "1.licks for people for therapeutic and prophylactic uses, packaged for retail trade, not in aerosol packaging, does not contain any narcotic drugs: krestor, film coated tablets, 10 mg of 14 tablets in a blister, 2 blister cards in a cardboard box (active ingredient - 1 film coated film, contains 10 mg of rosuvastatin in the form of 10.40 mg of rosuvastatin calcium) - 70 u.series my284. shelf life 07.2019.krester, film coated tablets, 20 mg per 14 tablets in the blister , 2 blister cards in a cardboard box(active ingredient - 1 film coated tablet contains 20 mg of rosuvastatin in the form of 20.80 mg of rosuvastatin calcium) - 70 u.series my719. shelf life 10.2019. trademark: astrazeneca; manufacturer: manufacturer of "in bulk" drug - aippier pharmaceuticals inc., puerto rico, usa; manufacturer responsible for packaging, control and serial production - astrazenecka uc limited, uk; country of production: pr; | PUERTO RICO | ****** | UA125030 | 3.71 | 2,102.13 | ***** | |
| 28/Apr/2017 | 3004900000 | "1.likarski facilities for people dlyaterapevtychnoho use, put up for retail sale (not containing penicillin, antibiotics, hormones, alkoloyidy, vitamins, spolukyyodu), not in aerosol upakovtsi.dykloberl � 100 suppositories 100 mg №10 (5x2) in blisters / active substances: 1supozytoriy contains diclofenac sodium 100 mg / berlin-chemie ag, nimechchynadykloberl � 50 suppositories 50 mg number 10 (5x2) in a blister / active substance 1 suppository contains diclofenac sodium 50 mg / producer: berlin-chemie ag nimechchynadykloberl � 50 tablets, film coated shell�th, 50 mg enteric №50 (10h5) in a blister / active substances: 1 tablet mistytdyklofenaku sodium 50 mg / berlin-chemie ag (manufacturer performs vyrobnytstvopreparatu "" in bulk "" and control of the series, the manufacturer performs the final packaging control and batch release) nimechchynaarlevert � tablets number 50 (25h2) in a blister / active substance: 1 tablet contains cinnarizine 20 mg tadymenhidrynatu 40 mg / hennig artsnaymittel gmbh & co. kg., nimechchy naarlevert � tablets number 20 (20x1) in a blister / active substance: 1 tablet contains 20 mg cinnarizine tadymenhidrynatu 40 mg / henn�g artsnaymittel gmbh & co. kg., nimechchynahennih artsnaymittel gmbh & co. kg., nimechchynalerkamen � 10 tablets covered with film-coated, 10 mg number 60 (15h4) ublisterah / active substance: 1 tablet contains lerkanidypinuhidrohlorydu 10 mg / berlin-chemie ag nimechchynalerkamen � 10 tablets covered with film-coated, 10 mg number 28 (14h2) ublisterah / active substance: 1 tablet contains lerkanidypinuhidrohlorydu 10 mg / berlin-chemie ag, nimechchynalerkamen � 20 tablets covered with film-coated, 20 mg number 28 (14h2 ) ublisterah / active substance: 1 tablet contains chaser�nidypinuhidrohlorydu 20 mg / berlin-chemie ag (production of drugs "" in bulk "" and batch control, final packaging control and batch release) nimechchynalerkamen � 20 tablets covered with film-coated, 20 mg number 60 (10h6) ublisterah / active ingredients: 1 tablet contains 20 mg lerkanidypinuhidrohlorydu / berlin-chemie ag (production of drugs "" in bulk "" and batch control, final packaging control and batch release) nimechchynamezym� 20000 forte tablets enteric number 20 (10x2) in a blister / active ingredients: 1 tablet containing enteric powder of pancreas�s zalozsvyney 200-266, 67 mg minimum lipolytic activity of 20, 000 iu ef, minimal amylase activity of 12000 u ef, minimum proteolitychnuaktyvnist ef 900 iu / berlin-chemie ag, nimechchynanebilet � tablets 5 mg number 28 (14h2) in a blister / active substance: 1 tablet contains nebivolol 5 mg / producer: berlin-chemie ag, nimechchynanebilet � tablets 5 mg number 14 (14h1) in a blister / active substance: 1 tablet contains nebivolol 5 mg / the berlin chemie ag, nimechchynatryfas � 10 mg tablets 10 number 100 (10x10) in blisters / active substance: 1 tablet contains 10 mg torasemide / burley�h-chemie ag (production of tablets in bulk;�batch control;�final packaging control and batch release) nimechchynaberlipryl � plus 10/25 tablets 10 mg " | GERMANY | ****** | UA110120 | 1,567.94 | 190,337.33 | ***** | |
| 28/Apr/2017 | 3004900000 | 1.nezareyestrovani drugs for people who are exclusively for clinical trial, clinical trial protocols av14001: masitynib 100 mg (masitinib 100 mg) or placebo tablets coated 30 tablets in a bottle - 360 flakoniv.seriynyy number: 1605788, 1603234pakuvalna series 521/59/33 vdiysnyy to 01/05 / 2019masitynib 200 mg (masitinib 200 mg) or placebo tablets coated 30 tablets in a bottle - 390 flakonivseriynyy number: 1609019, 1603942pakuvalna series 521/59/34 vdiysnyy 31 / 07 / 2019za clinical trial protocol av07015: masitynib 100 mg (masitinib 1 00 mg) or placebo tablets coated tablets in a bottle 30 - 90 flakoniv.seriynyy number: 1605788, 1603234pakuvalna series 521/59/29 vdiysnyy to 01/05 / 2019masitynib 200 mg (masitinib 200 mg) or placebo tablets coated 30 tablets in a bottle - 440 flakonivseriynyy number: 1609019, 1603942pakuvalna series 521/59/34 vdiysnyy 31/07 / 2019za protocol of clinical tests in av07002: masitynib 100 mg (masitinib 100 mg) or placebo tablets coated 30 tablets in a bottle - 250 flakoniv.seriynyy number: 1605788, 1603234pakuvalna series 521/59/29 vdiysnyy to 01/05 / 2019masitynib 200 mg (masitinib 200 mg) or platz oh, tablets coated 30 tablets in a bottle - 350 flakonivseriynyy number: 1609019, 1603942pakuvalna series 521/59/34 vdiysnyy 31/07 / 2019za protocol clinical trial av09004: masitynib 100 mg (masitinib 100 mg) or placebo tablets coated 30 tablets in a bottle - 135 flakoniv.seriynyy number: 1605788, 1603234pakuvalna series 521/59/29 vdiysnyy to 01/05 / 2019masitynib 200 mg (masitinib 200 mg) or placebo tablets coated 30 tablets in a bottle - 220 flakonivseriynyy number: 1609019, 1603942pakuvalna series 521/59/34 vdiysnyy 31/07 / 2019za clinical trial protocol av10004: masi ynib 100 mg (masitinib 100 mg), coated tablets 30 tablets in a bottle - 10 flakoniv.seriynyy number: 1600846pakuvalna series 5214929adiysnyy 31.12.2018masitynib to 200 mg (masitinib 200 mg), coated tablets 30 tablets in a bottle - 11 flakonivseriynyy number: 1607047pakuvalna series 5214932adiysnyy 01.05.2019masitynib to 200 mg (masitinib 200 mg), coated tablets 30 tablets in a bottle - 29 flakonivseriynyy number: 1609019pakuvalna series 5214936adiysnyy to 31.07.2019za clinical trial protocol av12008: masitynib 100 mg (masitinib 100 mg), coated tablets coated tablets in a bottle 30 - 20 flakoniv.seriynyy number: 1600846pakuvalna series 521/49 / 29diysnyy 31.12.2018masitynib to 200 mg (masitinib 200 mg), coated tablets 30 tablets in a bottle - 38 flakonivseriynyy number: 1609019pakuvalna series 521/49 / 36diysnyy 31.07.2019masitynib to 200 mg ( masitinib 200 mg), coated tablets 30 tablets in a bottle - 12 flakonivseriynyy number: 1607047pakuvalna series 521/49 / 32diysnyy 01.05.2019ne to contain material of human origin, antibiotics, hormones, vitamins, alcala | GERMANY | ****** | UA125100 | 85.55 | 1,246.93 | ***** | |
| 28/Apr/2017 | 3004900000 | 1.nezareyestrovani drugs for people who are exclusively for clinical trial, clinical trial protocols ab12005: gemcitabine accord 2g (2000mg), powder for injections lot number pt00750 valid until 11 / 2018- 40 upakovok.za clinical trial protocol ab12008: gemcitabine accord 2g (2000mg), powder for injections lot number pt00750 valid until 11 / 2018- 30 upakovok.ne contain material of human origin, antibiotics, hormones, vitamins, alkaloids or their derivatives, narcotic and psychotropic substances, precursors and iodine compounds iodine.�for clinical trials, not for sale.�packaging - plastic bottle in a cardboard box.�not in aerosol packaging.�. | INDIA | ****** | UA125100 | 3.50 | 43.85 | ***** | |
| 28/Apr/2017 | 3004900000 | 1. drugs, not retailers, not in aerosol packaging dlyaklinichnyh medical tests, code research ixa-csp-001: - litoksetyn capsules 10 mg., 20 mg or placebo for 30 capsules in bottles of 2flakona (a bottle and bottle b) in a cardboard box - 40 packs.�series 16l12.- litoksetyn capsules 10 mg., 20 mg or placebo for 30 capsules in bottles of 2flakona (vial a and vial b) in a cardboard box, 7 packs a kartonniypachtsi - 28 pack.�series production 16l12.torhivelna mark pharmavize.krayina be.�the company manufacturer pharmavize nv.�. | BELGIUM | ****** | UA100240 | 21.80 | 4,311.05 | ***** | |
| 28/Apr/2017 | 3004900000 | "1.liky for people without content, vitamins, hormones, alkaloids, antibiotics for rozdribnoi trade, not aerosol packaging: arymideks, tablets, film-coated shell in 1 mg №28 (14h2) in a blister / anastrozolvyrobnyk farmasyutykals astrazeneca lp ( drug manufacturer "" in bulk ""), sshaastrazeneka uk limited (the manufacturer responsible for packaging and batch release), uk; trademark - "" astrazeneca uk "". " | UNITED STATES | ****** | UA110030 | 0.34 | 1,537.80 | ***** | |
| 28/Apr/2017 | 3004900000 | "1.licks for people for therapeutic and prophylactic uses, packaged for retail trade, not in aerosol packaging, do not contain narcotic drugs: combogliza xr, tablets coated with 5 mg / 500 mg film, 7 tablets in a blister, 4 cardboard blister cards box (active ingredient -1 film coated tablet contains 5.58 mg of saxagliptin hydrochloride anhydrous, converted to saxagliptin 5 mg and 502.5 mg metformin hydrochloride, referring to metformin 500 mg) - 24 u.series hk0377. shelf life 05.2018. combogl�iza xr, film coated tablets, 2.5 mg / 1000 mg per 7 tablets in a blister, 4 blisters in a cardboard box (active ingredient - 1 film coated film contains 2.79 mg of saxagliptin hydrochloride anhydrous in the list for saxagliptin 2.5 mg and 1005 mg metformin hydrochloride, for metformin 1000 mg) - 60up.series hk0065. shelf life 06.2018.trademaster: astrazeneca; production: bristol-myers squibb company, usa; country of production: us; " | UNITED STATES | ****** | UA125030 | 7.67 | 1,694.17 | ***** | |
| 28/Apr/2017 | 3004900000 | 1. drugs for people dlyaterapevtychnoho application rozfasovanidlya retailers: tsyfran od, tablets, extended release coated film coated on 5tabletok to 1000 mg in a blister, 1 blister in a cardboard box series 2854561 - 144up. (active substances - 1 tablet contains ciprofloxacin hydrochloride equivalent to 1000 mg ciprofloxacin) tsyfran od, tablets, extended release coated film coated on 5tabletok to 500 mg in a blister, 1 blister in a cardboard box series 2853175 - 216up. (active substances - 1 tablet contains ciprofloxacin g�idrohlorydu equivalent to ciprofloxacin 500 mg) trademark: tsyfran odkrayina production: invyrobnyk san pharmaceutical industries limited. | INDIA | ****** | UA125030 | 4.47 | 393.12 | ***** |
